BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 34537077)

  • 1. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.
    Rokicka D; Hudzik B; Wróbel M; Stołtny T; Stołtny D; Nowowiejska-Wiewióra A; Rokicka S; Gąsior M; Strojek K
    Cardiovasc Diabetol; 2024 Apr; 23(1):147. PubMed ID: 38685054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Liu C; Zhao Q; Ma X; Cheng Y; Sun Y; Zhang D; Liu X; Zhou Y
    Cardiovasc Diabetol; 2022 Jan; 21(1):11. PubMed ID: 35045846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Front Cardiovasc Med; 2021; 8():735637. PubMed ID: 34869637
    [No Abstract]   [Full Text] [Related]  

  • 10. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
    Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
    Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
    Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
    Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.
    Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
    Cardiovasc Diabetol; 2021 Feb; 20(1):43. PubMed ID: 33573649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
    Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
    Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
    Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events in patients undergoing complex coronary artery intervention: a large-scale cohort study.
    He J; Song C; Yuan S; Bian X; Lin Z; Yang M; Dou K
    Cardiovasc Diabetol; 2024 Jan; 23(1):15. PubMed ID: 38184591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study.
    Zhang Z; Zhao L; Lu Y; Meng X; Zhou X
    Cardiovasc Diabetol; 2023 Jun; 22(1):161. PubMed ID: 37386494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.